SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: dalroi who wrote (2255)1/23/2001 5:35:20 PM
From: scaram(o)ucheRead Replies (1) | Respond to of 4974
 
We know that the LKST munch is what actually set the sector right, not genomics.

;-)

Back in the dark ages, in this thread, some of us were begging CEOs to set egos aside and merge. Mirabelli was just smarter than everyone else.

Yeah, expect munches.



To: dalroi who wrote (2255)1/23/2001 6:33:26 PM
From: BiomavenRespond to of 4974
 
stefaan,

We anticipate that shares outstanding will increase at approximately the same rate (5-10%) as previous years

This is likely to keep hungry optionees in shares when they exercise their options. Also for ESPP shares and perhaps for conversions - maybe they will call their convertibles like SEPR just did and force conversion. (Not actually sure if they are callable and I forget what's still out there in the way of convertibles).

Peter


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News